Ken Gordon

21 papers receiving 1.2k citations

Ken Gordon's Hit Papers

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial 2005 · 899 citations
8990+7+14Years since publication250500750

Peers

Ken Gordon
Comparison fields: 5 of 98
  • Biological Psychiatry 412
  • Behavioral Neuroscience 274
  • Immunology 539
  • Dermatology 195
  • Neurology 105
Replace Michael Woolley with:
Michael Woolley United States
Olawale Osuntokun United States
Lisa M. Thornton United States
Livia Sanna Italy
Harm de Wit Netherlands
Apurva Prakash United States
Mehmet Kaya Türkiye
Yajing Zhu China
Najib Aziz United States
Tatjana Dose Germany
Ken Gordon relative to Michael Woolley United States Michael Woolley's profile →
Citations per field
00.5×1.5×2.1×
Michael Woolley · 1×
Citations per year

Countries citing papers authored by Ken Gordon

Since Specialization
Citations

This map shows the geographic impact of Ken Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Gordon more than expected).

Fields of papers citing papers by Ken Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Gordon. The network helps show where Ken Gordon may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Gordon Line = papers co-authored together Ken Gordon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
Hit paper breakdown →
2005899
2 2012114
3 201856
4 199142
5 202041
6 199239
7 200936
8 199512
9 20039
10
CT and MR of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency.
19948
11 20246
12 20243
13
Angiotensin I-converting enzyme mutation (Y465D) cause dramatic increase in blood ACE via accelerated ACE shedding due to changes of ACE dimerization
20113
14 20192
15 20181
16 20221
17 20201
18 20081
19 19871
20 20111

About Ken Gordon

Ken Gordon is a scholar working on Immunology, Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine, Information Systems and Artificial Intelligence, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (12 papers), Pharmaceutical studies and practices (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Cloud Data Security Solutions (2 papers), Security and Verification in Computing (2 papers), Banking stability, regulation, efficiency (1 paper), Economic Policies and Impacts (1 paper) and Molecular Sensors and Ion Detection (1 paper). The work is most often cited by research in Biological Psychiatry (412 citations), Behavioral Neuroscience (274 citations), Immunology (539 citations), Dermatology (195 citations) and Neurology (105 citations). Ken Gordon has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Kim Papp, Alice B. Gottlieb, Ralph Zitnik, Deepa Lalla, Michael Woolley, Stephen K. Tyring, Angelika Jahreis, Ranga Krishnan, David Cella and Andrea Wang. Their work appears in journals such as Annals of the Rheumatic Diseases, British Journal of Dermatology, Epilepsia, ELT Journal and Queue.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact